Nika Biotechnology Stock Performance

NIKA Stock  USD 0.28  0.00  0.00%   
On a scale of 0 to 100, Nika BioTechnology holds a performance score of 2. The company secures a Beta (Market Risk) of -2.99, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Nika BioTechnology are expected to decrease by larger amounts. On the other hand, during market turmoil, Nika BioTechnology is expected to outperform it. Please check Nika BioTechnology's maximum drawdown, as well as the relationship between the skewness and day median price , to make a quick decision on whether Nika BioTechnology's current price movements will revert.

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Nika BioTechnology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile forward-looking signals, Nika BioTechnology sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
  

Nika BioTechnology Relative Risk vs. Return Landscape

If you would invest  29.00  in Nika BioTechnology on September 27, 2025 and sell it today you would lose (1.00) from holding Nika BioTechnology or give up 3.45% of portfolio value over 90 days. Nika BioTechnology is currently generating 0.2642% in daily expected returns and assumes 8.3132% risk (volatility on return distribution) over the 90 days horizon. In different words, 74% of pink sheets are less volatile than Nika, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Nika BioTechnology is expected to generate 11.67 times more return on investment than the market. However, the company is 11.67 times more volatile than its market benchmark. It trades about 0.03 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

Nika BioTechnology Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Nika BioTechnology's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Nika BioTechnology, and traders can use it to determine the average amount a Nika BioTechnology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0318

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsNIKA
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns
Based on monthly moving average Nika BioTechnology is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nika BioTechnology by adding it to a well-diversified portfolio.

About Nika BioTechnology Performance

By analyzing Nika BioTechnology's fundamental ratios, stakeholders can gain valuable insights into Nika BioTechnology's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Nika BioTechnology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Nika BioTechnology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
International Professional Trainings Group Limited provides online and face-to-face under-graduate and graduate university studies, professional training, study tours, and consulting services. The company was incorporated in 1999 and is based in North Las Vegas, Nevada. Nika Biotechnology is traded on OTC Exchange in the United States.

Things to note about Nika BioTechnology performance evaluation

Checking the ongoing alerts about Nika BioTechnology for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Nika BioTechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Nika BioTechnology had very high historical volatility over the last 90 days
Nika BioTechnology has some characteristics of a very speculative penny stock
Evaluating Nika BioTechnology's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Nika BioTechnology's pink sheet performance include:
  • Analyzing Nika BioTechnology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nika BioTechnology's stock is overvalued or undervalued compared to its peers.
  • Examining Nika BioTechnology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Nika BioTechnology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nika BioTechnology's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Nika BioTechnology's pink sheet. These opinions can provide insight into Nika BioTechnology's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Nika BioTechnology's pink sheet performance is not an exact science, and many factors can impact Nika BioTechnology's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Nika Pink Sheet analysis

When running Nika BioTechnology's price analysis, check to measure Nika BioTechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nika BioTechnology is operating at the current time. Most of Nika BioTechnology's value examination focuses on studying past and present price action to predict the probability of Nika BioTechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nika BioTechnology's price. Additionally, you may evaluate how the addition of Nika BioTechnology to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Global Correlations
Find global opportunities by holding instruments from different markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk